In Brief: Anti-obesity drugs
This article was originally published in The Tan Sheet
Executive Summary
Anti-obesity drugs: FDA's Endocrinologic & Metabolic Drugs Advisory Committee will discuss guidance criteria for development of medications to treat obesity beginning at 10 a.m. on July 14 at the Holiday Inn in Silver Spring, Md. The committee earlier discussed the topic at a January meeting...